Top Stories

• 

  Davis Polk, Slaughter & May Steer GSK's $10.6B Nuvalent Deal

  By Dawood Fakhir

  Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10....(read more)

• 

  OpenAI Joins Anthropic In Confidentially Filing IPO Plans

  By Hailey Konnath

  OpenAI said Monday that it had confidentially submitted a proposed initial public offering to the U.S. Securitie...(read more)

• 5 Firms Advise On Apollo-Led $35B Broadcom AI Financing

  By Al Barbarino

  Apollo Global Management said Tuesday it is leading a $35 billion capital commitment for a Broadcom initiative to build artificial intelligence infrastructure for companies including Anthropic and OpenAI, with Blackstone also participating.

• Senate Confirms Kansas Prosecutor To Federal Bench

  By Courtney Bublé

  The Senate voted 51-46, along party lines, on Tuesday to confirm Tony Mattivi, director of the Kansas Bureau of Investigation, to serve on the bench in the District of Kansas.

• Novanta Buys Riverpoint In $1.45B Deal Steered By 3 Firms

  By Jade Martinez-Pogue

  Medical technology provider Novanta Inc., advised by Ropes & Gray LLP and King & Spalding LLP, on Tuesday announced plans to acquire medical device maker Riverpoint Medical, led by Goodwin Procter LLP, from private equity shop Arlington Capital Partners in a deal worth up to $1.45 billion.

• Telecom Managers Deny $20M Fraud As Feds Float Plea Talks

  By Pete Brush

  Three managers from the U.S. arm of Telekom Malaysia denied fraud and identity theft charges Tuesday in Manhattan federal court, as prosecutors who charge them with stealing $20 million from their overseas parent suggested plea talks could get underway.

• All Attys In Miss. Suit DQd For Back-To-Back-To-Back AI Flubs

  By Emily Sawicki

  A Mississippi federal judge who found herself in the "unusual scenario" of reviewing briefs with artificial intelligence-created errors filed by both parties in a lawyer's fee dispute against a Magnolia State municipality has terminated all four attorneys from the case.

• Paramount's $110B Deal For Warner Bros. Faces UK Probe

  By Dawood Fakhir

  Britain's competition watchdog said Tuesday that it has launched a formal probe into Paramount Skydance's $110 billion deal to buy Warner Bros. Discovery Inc. after it sought initial views on the acquisition in April.

• 9th Circ. Judge Faces Inquiry, Charges After Idaho Altercation

  By Lauren Berg

  The Ninth Circuit on Monday identified a judicial misconduct complaint against U.S. Circuit Judge Ryan D. Nelson after he was charged with misdemeanor battery stemming from an argument in an Idaho Falls parking lot that ended with him allegedly stomping a man's eyeglasses on the asphalt.

• FCC Considering 120-Day Deadline For Permit Approvals

  By Nadia Dreid

  The Federal Communications Commission plans to propose telling states and municipalities that they have four months to act on applications before it will presume they've "effectively prohibited the provision of wireline telecommunications services," as part of a push to reduce what it perceives as barriers to broadband deployment.

• DC Judge Undoes IRS Wind, Solar Tax Credit Limitations

  By Ganesh Setty

  A D.C. federal judge has vacated an Internal Revenue Service notice limiting how wind and large-scale solar projects can qualify for two Biden-era clean energy tax credits, finding the Trump administration didn't sufficiently consider reliance interests and explain its rationale for the change.

• Fed. Circ. Panel Backs Invalidation Of OxyContin Patent

  By Theresa Schliep

  The Federal Circuit on Monday upheld a Delaware federal court's decision that deemed invalid a Purdue Pharma patent covering an abuse-deterrent version of the opioid OxyContin, rebuffing the company's arguments that the lower court got its obviousness analysis wrong.

• Todd Blanche Officially Nominated To Be AG

  By Courtney Bublé

  President Donald Trump on Monday officially nominated Todd Blanche to be attorney general.

• Biogen To End Investors' Alzheimer's Drug Case For $18.9M

  By Jessica Corso

  Biogen Inc. has agreed to pay $18.9 million to exit a lawsuit accusing it of misleading investors about the commercial readiness of a new Alzheimer's treatment, according to a settlement filed in Massachusetts federal court.